Unique Product Quality Considerations in Vaccine Development, Registration and New Program Implementation in Malaysia

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1667206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited